Clinical Trial Study on the Improved New Method of Acupotomy for AS
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Ankylosing Spondylitis
In brief
This study employs a randomized controlled trial methodology to systematically evaluate the efficacy and safety of a modified acupotomy technique in the treatment of ankylosing spondylitis. Through ultrasound-guided localization, the operative sites are assessed to clarify the improvement effect of the modified acupotomy on disease activity in AS patients. The aim is to enhance the clinical outcomes of AS, provide evidence-based medical support for acupotomy treatment of AS, and improve the diagnosis and treatment standards for the condition.
Key facts
- Study ID
- NCT07578220
- Run by
- China-Japan Friendship Hospital
- People needed
- 60
- Starts
- 2025-12-02
- Expected to finish
- 2029-06-30
- Last updated by the study team
- 2026-05-13
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Meeting the 1984 revised New York criteria or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis
- Age 18-75 years
- BASDAI ≥4
- Signed informed consent form
You may not qualify if…
- Presence of autoimmune diseases other than the studied condition
- Complete spinal ankylosis or spinal deformity
- Pregnant or lactating women
- Comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, malignant tumors, or coagulation disorders
- Patients unable to comply with data collection due to mental, linguistic, or similar factors
- Patients with psoriatic arthritis, reactive arthritis, or inflammatory bowel disease-associated spondyloarthritis
Where it is running
- The Second Affiliated Hospital of Henan University of Chinese Medicine — Henan, Zhengzhou, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.